Editing Atrophy

{{hatgrp|
{{distinguish|Entropy}}
{{For|the American thrash metal band|Atrophy (band)}}
}}
{{Short description|Partial or complete wasting away of a part of the body}}
{{Infobox medical condition (new)
| name          = Atrophy
| image         = Mouse_with_spinal_muscular_atrophy.jpg
| caption       = Mouse (right) with spinal muscular atrophy
| field         = [[Pathology]]
| pronounce     = 
| synonyms      = 
| symptoms      = Loss of body cells, signs of [[ageing]]
| complications = 
| onset         = 
| duration      = 
| types         = [[Muscular atrophy]], gland atrophy
| causes        = Poor nourishment, poor circulation, loss of hormonal support, loss of nerve supply to target organ(s), excessive [[apoptosis]] of cells, insufficient exercise, ageing
| risks         = Old age, sedentary lifestyle
| diagnosis     = 
| differential  = 
| prevention    = 
| treatment     = 
| medication    = 
| prognosis     = Depends on the cause
| frequency     = 
| deaths        = 
}}

'''Atrophy''' is the partial or complete [[wasting]] away of a part of the body. Causes of atrophy include [[mutation]]s (which can destroy the gene to build up the organ), [[malnutrition|poor nourishment]], poor [[circulatory system|circulation]], loss of [[hormone|hormonal]] support, loss of [[nerve]] supply to the target [[Organ (anatomy)|organ]], excessive amount of [[apoptosis]] of cells, and disuse or lack of [[exercise]] or disease intrinsic to the tissue itself. In medical practice, hormonal and nerve inputs that maintain an organ or body part are said to have ''trophic'' effects. A diminished muscular trophic condition is designated as ''atrophy''. Atrophy is reduction in size of cell, organ or tissue, after attaining its normal mature growth. In contrast, [[hypoplasia]] is the reduction in the cellular numbers of an organ, or tissue that has not attained normal maturity.

Atrophy is the general [[physiological]] process of reabsorption and breakdown of [[biological tissue|tissues]], involving apoptosis. When it occurs as a result of disease or loss of trophic support because of other diseases, it is termed ''pathological atrophy'', although it can be a part of normal body development and [[homeostasis]] as well.

==Normal development==
{{-plasia}}
Examples of atrophy as part of normal development include shrinking and the involution of the [[thymus]] in early childhood, and the [[tonsil]]s in adolescence. In old age, effects include, but are not limited to, loss of teeth, hair, thinning of skin that creates wrinkles, weakening of muscles, loss of weight in organs and sluggish mental activity.<ref>{{cite book|title=Disease and Its Causes|year=1913|publisher=New York Henry Holt and Company London [[Williams and Norgate]] The University Press, Cambridge, U.S.|url= https://www.gutenberg.org/files/15283/15283-h/15283-h.htm#toc_5 |author=W. T. Councilman|chapter=Chapter Two}}</ref>

==Muscle atrophies==
{{Main|Muscle atrophy}}

''Disuse atrophy'' of muscles and bones, with loss of mass and strength, can occur after prolonged immobility, such as extended [[bedrest]], or having a body part in a cast (living in darkness for the eye, bedridden for the legs etc.). This type of atrophy can usually be reversed with exercise unless severe.

There are many diseases and conditions which cause atrophy of muscle mass. For example, diseases such as cancer and AIDS induce a body wasting syndrome called ''[[cachexia]]'', which is notable for the severe muscle atrophy seen. Other syndromes or conditions which can induce [[skeletal striated muscle|skeletal muscle]] atrophy are [[congestive heart failure]] and liver disease.

During aging, there is a gradual decrease in the ability to maintain skeletal muscle function and mass. This condition is called ''[[sarcopenia]]'', and may be distinct from atrophy in its pathophysiology. While the exact cause of sarcopenia is unknown, it may be induced by a combination of a gradual failure in the [[satellite cells]] which help to regenerate skeletal muscle fibers, and a decrease in sensitivity to or the availability of critical secreted growth factors which are necessary to maintain muscle mass and satellite cell survival.<ref>{{cite web | url = https://www.nlm.nih.gov/medlineplus/ency/article/003188.htm | title = Muscle atrophy | publisher= [[MedlinePlus]] | access-date = 2007-10-02 | date = 2007-05-22 | last = Campellone | first = Joseph V. | archive-url= https://web.archive.org/web/20071013000952/http://www.nlm.nih.gov/medlineplus/ency/article/003188.htm| archive-date= 13 October 2007 | url-status= live}}</ref>

== Dystrophies, myositis, and motor neuron conditions ==

Pathologic atrophy of muscles can occur with diseases of the motor nerves or diseases of the muscle tissue itself. Examples of atrophying nerve diseases include [[Charcot-Marie-Tooth disease]], [[poliomyelitis]], [[amyotrophic lateral sclerosis]] (ALS or Lou Gehrig's disease), and [[Guillain–Barré syndrome]]. Examples of atrophying muscle diseases include [[muscular dystrophy]], [[myotonia congenita]], and [[myotonic dystrophy]].

Changes in Na+ channel isoform expression and spontaneous activity in muscle called fibrillation can also result in muscle atrophy.

A [[flail limb]] is a medical term which refers to an extremity in which the primary nerve has been severed, resulting in complete lack of mobility and sensation. The muscles soon wither away from atrophy.

==Gland atrophy==

The [[adrenal gland]]s atrophy during prolonged use of exogenous [[glucocorticoid]]s like [[prednisone]]. Atrophy of the breasts can occur with prolonged [[estrogen]] reduction, as with [[anorexia nervosa]] or [[menopause]]. [[Testicular atrophy]] can occur with prolonged use of enough exogenous [[sex steroid]]s (either [[androgen]] or [[estrogen]]) to reduce [[gonadotropin]] secretion.

==Vaginal atrophy==

In post-menopausal women, the walls of the vagina become thinner ([[atrophic vaginitis]]). The mechanism for the age-related condition is not yet clear, though there are theories that the effect is caused by decreases in estrogen levels.<ref>{{cite web| url= http://medicine.science-tips.org/health/diseases-and-conditions/types-of-atrophy.html| title= Types of Atrophy| access-date= 2007-10-02| archive-url= https://web.archive.org/web/20070928072029/http://medicine.science-tips.org/health/diseases-and-conditions/types-of-atrophy.html| archive-date= 28 September 2007| url-status= dead}}</ref>  This atrophy, occurring concurrently with [[breast atrophy]], is consistent with the homeostatic (normal development) role of atrophy in general, as after menopause the body has no further functional biological need to maintain the reproductive system which it has permanently shut down.

==Research==
One drug in test seemed to prevent the type of muscle loss that occurs in immobile, bedridden patients.<ref name="ND2006">{{cite news|url=http://www2.netdoctor.co.uk/news/index.asp?y=2006&m=5&d=25&id=123026 |archive-url=https://web.archive.org/web/20070911010834/http://www2.netdoctor.co.uk/news/index.asp?y=2006&m=5&d=25&id=123026 |url-status=dead |archive-date=2007-09-11 |title=Drug could stop muscle wasting' |publisher=NetDoctor.co.uk |date=2006-05-25 |access-date=2006-05-27 }}</ref>
Testing on mice showed that it blocked the activity of a protein present in the muscle that is involved in muscle atrophy.<ref name="FASEBJ2006-Wang">{{cite journal | vauthors=Wang X, Hockerman GH, Green Iii HW, Babbs CF, Mohammad SI, Gerrard D, Latour MA, London B, Hannon KM, Pond AL | title=Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway | journal=FASEB J | date=May 24, 2006 | pmid=16723379 | volume=20 | pages=1531–3 | doi=10.1096/fj.05-5350fje | issue=9| doi-access=free | s2cid=15763153 }}</ref> However, the drug's long-term effect on the heart precludes its routine use in humans, and other drugs are being sought.<ref name="ND2006" />

== See also ==
* [[Olivopontocerebellar atrophy]]
* [[Optic atrophy]]
* [[Spinomuscular atrophy]]
* [[Hypertrophy]]
* [[Deconditioning]]
* [[List of biological development disorders]]

==References==
{{Reflist}}

== External links ==
* {{cite EB9 |wstitle= Atrophy |volume= III |pages=50-51 |short=1}}


{{Medical resources
| DiseasesDB      = 
| ICD10           = 
| ICD9            = 
| ICDO            = 
| OMIM            = 
| MedlinePlus     = 
| eMedicineSubj   = 
| eMedicineTopic  = 
| MeshID          = D001284
| SNOMED CT       = 13331008
}}
{{Pathology}}
{{Clinical and histological nomenclature for skin lesions}}
{{Authority control}}

[[Category:Anatomical pathology]]
[[Category:Gross pathology]]